Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Donna Bracken"'
Publikováno v:
Journal of Central Nervous System Disease, Vol 2010, Iss 2, Pp 57-72 (2010)
Externí odkaz:
https://doaj.org/article/80abafab15154a65bd55b1734f9ec8bd
Publikováno v:
The Journal of Pain. 12:1113-1129
Gout is a relatively common inflammatory arthritis that is typically known to occur in middle-aged men. The prevalence of gout appears to be shifting, however, and is increasing in the elderly population. Gout is characterized by severely intense pai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::078b7fda5aa6bdc84fc5480ac5e11226
https://doi.org/10.1016/j.jpain.2011.06.009
https://doi.org/10.1016/j.jpain.2011.06.009
Publikováno v:
Journal of Central Nervous System Disease, Vol 2010, Iss 2, Pp 57-72 (2010)
Journal of Central Nervous System Disease, Vol 2 (2010)
Journal of Central Nervous System Disease
Journal of Central Nervous System Disease, Vol 2 (2010)
Journal of Central Nervous System Disease
Fibromyalgia (FM) is a chronic disorder characterized by widespread pain and other associated symptoms including fatigue, insomnia, cognitive/memory problems, and even psychological distress. Duloxetine is one of three FDA approved medications (the o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6733bbaaca008f332016de7d959be0bd
http://www.la-press.com/duloxetine-a-review-of-its-safety-and-efficacy-in-the-management-of-fi-a2421
http://www.la-press.com/duloxetine-a-review-of-its-safety-and-efficacy-in-the-management-of-fi-a2421
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 2 (2011)
Frontiers in Pharmacology, Vol 2 (2011)
Fibromyalgia (FM) is a chronic disorder characterized by multifocal pain and other associated somatic symptoms including fatigue, insomnia, cognitive/memory problems, and even psychological distress. It appears that 2–4% of the general population s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40aefd21a15e2519bd1f5da9bf1e8a9a
https://doi.org/10.3389/fphar.2011.00017
https://doi.org/10.3389/fphar.2011.00017